Flagship Harbor Advisors’s ResMed RMD Stock Holding History

Flagship Harbor Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21	Closed	-$5.06K	–	1858
2025 Q4	$5.06K	Buy	+21	New	+$5.37K	﹤0.01%	1657
2020 Q4	–	Sell	-113	Closed	-$19K	–	1495
2020 Q3	$19K	Sell	113 -33	-23%	-$6.09K	﹤0.01%	1161
2020 Q2	$28K	Buy	146 +45	+45%	+$7.36K	﹤0.01%	1035
2020 Q1	$15K	Buy	101 +76	+304%	+$12.1K	﹤0.01%	1120
2019 Q4	$4K	Hold	25	–	–	﹤0.01%	1586
2019 Q3	$3K	Hold	25	–	–	﹤0.01%	1622
2019 Q2	$3K	Hold	25	–	–	﹤0.01%	1624
2019 Q1	$2K	Hold	25	–	–	﹤0.01%	1696
2018 Q4	$2K	Hold	25	–	–	﹤0.01%	1664
2018 Q3	$3K	Hold	25	–	–	﹤0.01%	1839
2018 Q2	$2K	Buy	+25	New	+$2.53K	﹤0.01%	1873

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Flagship Harbor Advisors's RMD Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of ResMed (RMD) in Q1 2026, closing a stake of 21 shares — an estimated $5.06K sold.

Flagship Harbor Advisors first reported a position in RMD in Q2 2018 and held it in 11 quarters. The position peaked at $28K in Q2 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Flagship Harbor Advisors reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Flagship Harbor Advisors sold 21 ResMed shares in Q1 2026, an estimated $5.06K.
Flagship Harbor Advisors first reported a position in ResMed in Q2 2018 and held it in 11 quarters.
Flagship Harbor Advisors's ResMed position peaked at $28K in Q2 2020.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.